-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the enterprise survey app, recently, Shanghai Huanqi Xinpeptide Technology Co., Ltd. underwent business changes, adding Shanghai Lenovo Future Venture Capital Partnership as shareholders, and the registered capital increased to 2.64,400 yuan. According to enterprise research information, the company was founded in July 2026. Its business scope includes bio-based material technology research and development; industrial enzyme preparation research and development; artificial intelligence application software development; artificial intelligence industry application system integration services; artificial intelligence hardware sales, etc.
Share
Listen to the news
According to the enterprise survey app, recently, Shanghai Huanqi Xinpeptide Technology Co., Ltd. underwent business changes, adding Shanghai Lenovo Future Venture Capital Partnership as shareholders, and the registered capital increased to 2.64,400 yuan. According to enterprise research information, the company was founded in July 2026. Its business scope includes bio-based material technology research and development; industrial enzyme preparation research and development; artificial intelligence application software development; artificial intelligence industry application system integration services; artificial intelligence hardware sales, etc.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending